tiprankstipranks
Atrys Health SA (DE:A2T)
FRANKFURT:A2T
Holding DE:A2T?
Track your performance easily

Atrys Health SA (A2T) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Atrys Health SA’s (A2T) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Atrys Health SA is a Sell.
Atrys Health SA’s (A2T) 20-Day exponential moving average is 2.94, while Atrys Health SA’s (A2T) share price is €2.92, making it a Sell.
Atrys Health SA’s (A2T) 50-Day exponential moving average is 2.99, while Atrys Health SA’s (A2T) share price is €2.92, making it a Sell.

Atrys Health SA (A2T) Pivot Points

Dec 19, 2024, 12:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.57
2.64
2.79
2.86
3.01
3.08
3.23
Fibonacci
2.64
2.73
2.78
2.86
2.95
3.00
3.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atrys Health SA (A2T) Moving Averages

Dec 19, 2024, 12:49 PM
Period
Simple
Exponential
MA5
2.96Sell
2.95Sell
MA10
2.91Buy
2.93Sell
MA20
2.93Sell
2.94Sell
MA50
3.01Sell
2.99Sell
MA100
3.05Sell
3.06Sell
MA200
3.14Sell
3.14Sell
Atrys Health SA’s (A2T) 10-Day exponential moving average is 2.93, while Atrys Health SA’s (A2T) share price is €2.92, making it a Sell.
Atrys Health SA’s (A2T) 100-Day exponential moving average is 3.06, while Atrys Health SA’s (A2T) share price is €2.92, making it a Sell.
Atrys Health SA’s (A2T) stock price is €2.92 and Atrys Health SA’s (A2T) 50-day simple moving average is 3.01, creating a Sell signal.
Atrys Health SA’s (A2T) stock price is €2.92 and Atrys Health SA’s (A2T) 100-day simple moving average is 3.05, creating a Sell signal.
Atrys Health SA’s (A2T) stock price is €2.92 and Atrys Health SA’s (A2T) 200-day simple moving average is 3.14, creating a Sell signal.

Atrys Health SA (A2T) Technical Indicators

Dec 19, 2024, 12:49 PM
Name
Value
Implied Action
RSI (14)
48.15
Neutral
STOCH (9,6)
69.18
Neutral
STOCHRSI (14)
56.41
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
29.34
Neutral
Williams %R
-56.92
Buy
CCI (14)
-25.66
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
80.60
Buy
ROC
-1.35
Sell
Atrys Health SA’s (A2T) Relative Strength Index (RSI) is 48.15, creating a Neutral signal.
Atrys Health SA’s (A2T) Trend Strength Indicator (ADX) is 29.34, creating a Neutral signal.
Atrys Health SA’s (A2T) Commodity Channel Index (CCI) is -25.66, creating a Neutral signal.
Atrys Health SA’s (A2T) Price Rate of Change (ROC) is -1.35, creating a Sell signal.

FAQ

Is A2T a Buy, Hold, or Sell?
Based on A2T’s technical indicators, A2T is a Strong Sell.
    What is A2T’s RSI (14)?
    A2T’s RSI (14) is 48.15, which suggests A2T is a Neutral.
      What is A2T’s MACD?
      A2T’s MACD is -0.02, which suggests A2T is a Sell.
        What is A2T’s 5-day moving average?
        A2T’s 5-day moving average is 2.96, which suggests A2T is a Sell.
          What is A2T’s 20-day moving average?
          A2T 20-day moving average is 2.93, which suggests A2T is a Sell.
            What is A2T’s 50-day moving average?
            A2T’s 50-day moving average is 3.01, which suggests A2T is a Sell.
              What is A2T’s 200-day moving average?
              A2T’s 200-day moving average is 3.14, which suggests A2T is a Sell.
                What is A2T’s Williams % R (14)?
                A2T’s Williams % R (14) is -56.92, which suggests A2T is a Buy.
                  What is A2T’s CCI (14)?
                  A2T’s CCI (14) is -25.66, which suggests A2T is a Neutral.
                    What is the share price of Atrys Health SA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis